Joel Wagman is counsel in Herrick's Corporate Department. Joel's experience is diverse, and includes partnering and strategic alliances, mergers and acquisitions, and private equity and venture capital transactions for clients across a broad range of industries. He has substantial experience with complex securities law issues and also in financing and capital raising transactions, including private placements, initial public offerings, PIPEs and equity and debt restructuring. He negotiates and drafts stock and asset purchase agreements, joint venture agreements, research and development collaborations, and intellectual property licenses, as well as manufacturing, distribution, and sales representations and commercial sales agreements. He represents companies at various levels of business development in acquiring, developing and commercializing pharmaceutical products and devices. He also advises life sciences companies on matters involving research collaboration, development and consulting agreements and licensing.

Prior to joining Herrick, Joel was a partner in Goodwin Procter's Business Law Department and a member of its general corporate and life sciences practice areas.